NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE has the edge over SHOE overall, supported by stronger valuation and lower modeled downside.

SHOE

Shoe Station Group Inc.

32
Fundamentals35/ 100
Valuation20/ 100
Upside potential33/ 100
Risk potential46/ 100

SHOE's outlook is improving despite an expensive valuation.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

SHOE Fundamentals

MetricStatus
Stable
Stable
Healthy
Strong

SHOE's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE has the edge over SHOE in the historical PE scenario, which offers more potential upside but is not a forecast.

SHOE PE Valuation

CHEAPFAIREXPENSIVE18x36x54x72x
CHEAPFAIREXPENSIVE18x36x54x72x
LevelPEPriceVs current
Cheap6.3x$5.57-61%
Fair9.2x$8.12-43%
Forward10x$14.20—
Expensive15x$13.27-6.5%
Current16x$14.20—

Historical ranges are pointers, not guarantees.

SHOE's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

SHOE Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
High

SHOE has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE has a better modeled risk to reward balance than SHOE, with more potential upside and less potential downside.

SHOE Risk to reward

ScenarioChangePrice
Upside+23%$17.40
Downside-46%$7.72

Calculated from the latest close: $14.20 on Nov 12.

SHOE trails NKE on modeled risk to reward, with less potential upside and more potential downside.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

SHOE Earnings Per Share

Q4 2023: $2.90Q1 2024: $2.68Q2 2024: $2.71Q3 2024: $2.82Q4 2024: $2.72Q1 2025: $2.68Q2 2025: $2.39Q3 2025: $2.27Q4 2025: $2.10Q1 2026: $1.90Q2 2026: $1.35Q3 2026: $0.88Forward: $1.39
Q4 2023: $2.90Q1 2024: $2.68Q2 2024: $2.71Q3 2024: $2.82Q4 2024: $2.72Q1 2025: $2.68Q2 2025: $2.39Q3 2025: $2.27Q4 2025: $2.10Q1 2026: $1.90Q2 2026: $1.35Q3 2026: $0.88Forward: $1.39
QuarterTTM EPSYoY
Forward$1.39+58%
Q3 2026$0.88-61%
Q2 2026$1.35-44%
Q1 2026$1.90-29%
Q4 2025$2.10-23%
Q3 2025$2.27-20%
Q2 2025$2.39-12%
Q1 2025$2.680%
Q4 2024$2.72-6.2%

SHOE's earnings per share have fallen from their peak: $0.88 over the past year, against $5.42 in early 2022.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE has the edge over SHOE on sales, with more consistent year-over-year improvement.

SHOE Quarterly Revenue

Q4 2023: $320MQ1 2024: $280MQ2 2024: $300MQ3 2024: $333MQ4 2024: $307MQ1 2025: $263MQ2 2025: $278MQ3 2025: $306MQ4 2025: $297MQ1 2026: $254MQ2 2026: $271MQ3 2026: $284M
Q4 2023: $320MQ1 2024: $280MQ2 2024: $300MQ3 2024: $333MQ4 2024: $307MQ1 2025: $263MQ2 2025: $278MQ3 2025: $306MQ4 2025: $297MQ1 2026: $254MQ2 2026: $271MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$284.3M-7.2%
Q2 2026$270.7M-2.5%
Q1 2026$254.1M-3.4%
Q4 2025$297.2M-3.2%
Q3 2025$306.4M-7.9%
Q2 2025$277.7M-7.5%
Q1 2025$262.9M-6.1%
Q4 2024$306.9M-4.1%

SHOE's revenue has slid since its 2021 peak: $284M last quarter, down 7.2% from the same quarter a year ago.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.

SHOE Free Cash Flow

Q4 2023: $34MQ1 2024: $41MQ2 2024: $7MQ3 2024: $18MQ4 2024: $8MQ1 2025: $36MQ2 2025: −$23MQ3 2025: $2MQ4 2025: $20MQ1 2026: $28MQ2 2026: $13MQ3 2026: $7M
Q4 2023: $34MQ1 2024: $41MQ2 2024: $7MQ3 2024: $18MQ4 2024: $8MQ1 2025: $36MQ2 2025: −$23MQ3 2025: $2MQ4 2025: $20MQ1 2026: $28MQ2 2026: $13MQ3 2026: $7M
QuarterFree cash flowYoY
Q3 2026$6.5M+197%
Q2 2026$12.6M+$35.6M
Q1 2026$27.7M-24%
Q4 2025$19.7M+138%
Q3 2025$2.2M-88%
Q2 2025-$23M-435%
Q1 2025$36.2M-11%
Q4 2024$8.3M-76%

SHOE has the edge over NKE on cash flow, with more consistent year-over-year improvement.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has 1.5B diluted shares, about the same as a year ago.

SHOE Total Shares

Q4 2023: 27MQ1 2024: 27MQ2 2024: 27MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 27MQ3 2025: 27MQ4 2025: 28MQ1 2026: 28MQ2 2026: 27MQ3 2026: 27M
Q4 2023: 27MQ1 2024: 27MQ2 2024: 27MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 27MQ3 2025: 27MQ4 2025: 28MQ1 2026: 28MQ2 2026: 27MQ3 2026: 27M
PeriodChange %Net change
Quarterly-0.3%-72K shares
1 year-0.5%-140K shares
3 years-0.3%-95K shares
5 years-4.7%-1.3M shares
Available history-6.2%-1.8M shares

SHOE has the edge over NKE on shareholder dilution, with a more favorable share count trend.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

SHOE Net Leverage

Q4 2023: -0.5xQ1 2024: -0.8xQ2 2024: -0.5xQ3 2024: -0.6xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -0.7xQ3 2025: -0.7xQ4 2025: -0.9xQ1 2026: -1.2xQ2 2026: -1.4xQ3 2026: -1.8x
Q4 2023: -0.5xQ1 2024: -0.8xQ2 2024: -0.5xQ3 2024: -0.6xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -0.7xQ3 2025: -0.7xQ4 2025: -0.9xQ1 2026: -1.2xQ2 2026: -1.4xQ3 2026: -1.8x
QuarterNet LeverageStatus
Q3 2026-1.8xNet Cash
Q2 2026-1.4xNet Cash
Q1 2026-1.2xNet Cash
Q4 2025-0.9xNet Cash
Q3 2025-0.7xNet Cash
Q2 2025-0.7xNet Cash
Q1 2025-0.9xNet Cash
Q4 2024-0.6xNet Cash

SHOE has the edge over NKE on leverage, with a lower net debt burden relative to earnings.

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

SHOE Weekly Momentum

MetricValueStatus
RSI45.4Neutral
Stochastic71.0Neutral

SHOE's weekly RSI is 45 (neutral) and its Stochastic is 71 (neutral).

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

SHOE PE vs Consumer Cyclical Sector

MetricSHOESector medianRelative
PE16x18x10% below
PE %854738 pts above

SHOE has the edge over NKE on valuation relative to its sector.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

SHOE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$13.73.6% above
20 week MA$14.20.1% below
50 week MA$16.614% below
100 week MA$19.226% below
200 week MA$24.742% below

SHOE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

SHOE Yearly ROI

YearStart priceEnd priceROI
2020$18.4$19.4+5.3%
2021$19.4$39.3+102%
2022$39.3$24.5-38%
2023$24.5$30.2+23%
2024$30.2$35.7+18%
2025$35.7$18.1-49%
2026 YTD$18.1$14.2-21%

SHOE has the edge over NKE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key